Aadi Biosciences, Inc. is a company in the U.S. stock market and it is a holding in 19 U.S.-traded ETFs. AADI has around 697.0K shares in the U.S. ETF market. The largest ETF holder of AADI is the iShares Russell 2000 ETF (IWM), with approximately 325.43K shares. Investors may also find of interest that the ETF with the largest allocation to AADI stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 0.12%. On average, U.S. ETFs allocate 0.01% of AADI to their portfolios.
Additionally, AADI is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AADI as a holding is the Dimensional U.S. Targeted Value ETF (DFAT), with a return of 1.68%.